financetom
Business
financetom
/
Business
/
This French tycoon surpasses Jeff Bezos to be world’s richest person
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
This French tycoon surpasses Jeff Bezos to be world’s richest person
Aug 4, 2021 3:27 AM

Bernard Arnault, the chairman, and CEO of the French luxury conglomerate LVMH Moët Hennessy - Louis Vuitton, has become the world's richest person after Amazon founder Jeff Bezos' net worth fell $13.9 billion in a day.

Share Market Live

NSE

This is not the first time Arnault has topped the world’s richest list. He became the number one in December 2019, in January 2020, in May 2021, and again in July 2021.

The French tycoon owns a 47.5% share in LVMH, which has a market capitalisation of more than $400 billion. The subsidiaries of LMVH — including Louis Vuitton, Moët & Chandon, Hennessy cognac, Christian Dior, and Tiffany & Co — cover fashion, jewellery, cosmetics, wines, and spirits.

The luxury brand has been posting pre-pandemic sales figures in Asia and the USA. Not to forget, tourists flock LVMH's home European market for its coveted handbags and liquor. Further, the sales of LVMH are recording a dramatic rise in China as the country's economy comes out of the lull due to the COVID-19 pandemic.

Meanwhile, Amazon.com — of which Bezos holds an 11 percent share — posted weaker-than-expected second-quarter earnings. Nonetheless, the net worth of Bezos is still $13 billion more than that of Tesla and SpaceX chief Elon Musk.

Here’s the Forbes Real-Time Billionaires' list of the richest people in the world:

Bernard Arnault: $195.4 billion

Jeff Bezos: $192.4 billion

Elon Musk: $179.4 billion

Bill Gates: $131.6 billion

Mark Zuckerberg: $128.2 billion

Larry Page: $115.2 billion

Larry Ellison: $112.6 billion

Sergey Brin: $111.5 billion

Warren Buffett: $101.0 billion

Francoise Bettencourt Meyers: $92.0 billion

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved